News You Can Use… Pete Koval, PharmD Christina Adler, PharmD candidate Cone Health Family Medicine December 2014.

Slides:



Advertisements
Similar presentations
The Home INR Study (THINRS): Home INR Monitoring as Effective as Clinic-Based Care AK Jacobson, MD American Heart Association 2008 Scientific Sessions:
Advertisements

Statins in Renal Failure Andrea Fox Sunnybrook Health Science Center May 2010.
Plant stanol ester in the treatment and prevention guidelines 0.
Adriana Weinberg, MD University of Colorado Denver.
January 16, 2010 Monica Robinson Green, PharmD, BCPS.
News You Can Use… Pete Koval, PharmD Megan Radigan, PharmD Candidate Kira Letvak, PharmD Candidate Cone Health Family Medicine May 2015.
News You Can Use… Pete Koval, PharmD Lauren Hickman, PharmD Candidate Cone Health Family Medicine April 2015.
Michael Rollins, PharmD Candidate Cone Health Family Medicine
News You Can Use… Pete Koval, PharmD Alvin Oung, PharmD Cone Health Family Medicine March 2015.
News You Can Use… Pete Koval, PharmD Laura Evington, PharmD candidate Cone Health Family Medicine November 2014.
News You Can Use… Pete Koval, PharmD Kim Mitchell, PharmD candidate Cone Health Family Medicine October 2014.
Cone Health Family Medicine
News You Can Use… Pete Koval, PharmD Lauren Bajbus, PharmD Cone Health Family Medicine July 2014.
News You Can Use… Jessica Binz, PharmD Pete Koval, PharmD Cone Health Family Medicine September 2014.
Megan Shah, PharmD Candidate Cone Health Family Medicine
Next Generation Disease Management: Saving Healthcare Costs Through Medical Genomics © GenoMed, Inc
News You Can Use… Pete Koval, PharmD Tiffany Wong, PharmD Candidate Cone Health Family Medicine June 2014.
Clopidogrel Audit Vikas Jasoria December What is it? Clopidogrel is a thienopyridine antiplatelet drug which reduces platelet aggregation by inhibiting.
Cardiovascular Risk and NSAIDs Arthritis Advisory Committee Meeting November 29, 2006 Sharon Hertz, M.D. Deputy Director Division of Analgesia, Anesthesia,
News You Can Use… Stacey Karl, PharmD Pete Koval, PharmD Cone Health Family Medicine August 2015.
Jackie Skradski Pharm.D. Candidate 2016 Ferris State University College of Pharmacy February 25, 2015.
Tommi Cooke, PharmD Candidate 2016 Cone Health Family Medicine
Evaluating the Medical Evidence ​ A TOOLKIT FOR THE INTERPRETING THE EFFECTIVENESS OF INTERVENTIONS Niteesh Choudhy, M.D., Ph.D.
News You Can Use… Josh Stewart, PharmD Candidate 2016 Pete Koval, PharmD Cone Health Family Medicine October 2015.
News You Can Use… Nick Gazda, PharmD Candidate 2016 Pete Koval, PharmD Cone Health Family Medicine December 2015.
News You Can Use… Stacey Karl, PharmD Pete Koval, PharmD Cone Health Family Medicine January 2016.
ACC/AHA Guidelines Not the Final or Only Word. Contemporary Guidelines
Persida Tahiri, PharmD Candidate 2016 Cone Health Family Medicine
Antithrombotic Therapy in Peripheral Artery Disease Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention.
DIABETES INSTITUTE JOURNAL CLUB CARINA SIGNORI, D.O., M.P.H. DECEMBER 15, 2011 Atherothrombosis intervention in metabolic syndrome with low HDL/High Triglycerides:
Pharmacogenomics based personalized medicine: Are the standards of evidence requirements different from standards for Clinical-Based Personalized Medicine?
News You Can Use… Phillip Transou, PharmD Candidate Pete Koval, PharmD Cone Health Family Medicine June, 2016.
Cardiovascular and Gastrointestinal Outcomes in Clopidogrel Users on Proton Pump Inhibitors: Results of a Large Dutch Cohort Study 소화기 내과 R1 박지윤 Ofke S.
News You Can Use… Megan Supple, PharmD Pete Koval, PharmD Cone Health Family Medicine March 2016.
News You Can Use… Kristen Gray, PharmD Pete Koval, PharmD Cone Health Family Medicine April 4 th, 2016.
News You Can Use… Ethan Hammer, PharmD Candidate Pete Koval, PharmD Cone Health Family Medicine August, 2016.
News You Can Use… Simone Carden, PharmD Candidate Pete Koval, PharmD Cone Health Family Medicine July, 2016.
How Do We Individualize Guidelines in an Era of Personalized Medicine? Douglas K. Owens, MD, MS VA Palo Alto Health Care System Stanford University, Stanford.
Introduction. Adult ADHD in the Real World: From Clinical Trials to Clinical Practice.
Cone Health Family Medicine
Claudia Ortiz Lopez, PharmD Candidate Cone Health Family Medicine
Claudia Ortiz Lopez, PharmD Candidate Cone Health Family Medicine
Patrick Kurunwune, PharmD Candidate Cone Health Family Medicine
Cone Health Family Medicine
Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis.
VIOXX WITHDRAWAL: Learning valuable lessons from rofecoxib
Meredith Tilley, PharmD Candidate Cone Health Family Medicine
Antithrombotic Therapy in Peripheral Artery Disease
Anticoagulation in Atrial Fibrillation
Intensive Statin Recommendations
Selection of NSAIDs for Osteoarthritis
Click here for title Click here for subtitle
GAUSS-3 Trial design: Patients with objective evidence of intolerance to statin agents were randomized in a 2:1 fashion to either evolocumab 420 mg subcutaneously.
Cardiovascular Disease Risk Reduction Advances in Dyslipidemia
Up to Date on Which NOAC for Which Patient
How to Achieve Aggressive BP Goals in Difficult-to-Treat Patients
Hospital Based Inpatient Psych Care
Clarifying Optimal Patient Selection for Long-Term DAPT Post-MI
Evaluating LDL-C Recommendations
NOACS: Emerging data in ACS/IHD
PRECISION Trial design: Patients with arthritis and increased cardiovascular risk were randomized to celecoxib 100 mg twice daily (n = 8,072) vs. ibuprofen.
John Fanikos, RPh, MBA, Allison E. Burnett, PharmD, Charles E
New LDL-C Lipid Targets
Atrial Fibrillation.
CAD/PAD in Primary Care
Ezetimibe/simvastatin
Which NOAC and When for Stroke Prevention in AF?
Factor Xa Inhibitors in Coronary Artery Disease
Empowering Patients and Prescribers to Improve Treatment Adherence in Schizophrenia.
PCSK9 Inhibitors and Real-World Evidence
Presentation transcript:

News You Can Use… Pete Koval, PharmD Christina Adler, PharmD candidate Cone Health Family Medicine December 2014

Pradaxa vs Warfarin Two new studies have shown that Pradaxa has an increased risk of GI bleeding and major bleeding compared to warfarin The risk is greatest at the higher 150 mg twice daily dose One study found the risk is greatest in patients with CKD and those who are African American 11/05/2014 Web MD

COX-2 Inhibitors and Stroke Cox-2 inhibitors have been found to increase the risk of dying from stroke Current users were 19% more likely to die after stroke than non-users New Users were 42% more likely to die after stroke compared to non-users Avoid prescribing in patients with high risk of stroke 11/06/2014 Medical News Today

New FDA Approval Hysingla ER (hydrocodone barbiturate) is an FDA approved pain medication with abuse-deterrent properties Can not easily be crushed, broken or dissolved and forms a viscous hydrogel May be cost prohibitive 11/20/14 FDA News Release

Flu Vaccine in Children Three studies conducted during the flu season found FluMist the live attenuated vaccine ineffective against H1N1 in children 2-8 years old. The CDC has not changed its recommendation that FluMist is preferred in children 2-8 years old. 11/13/14 Facts & Comparisons News Brief

Outcomes Data for Zetia Zetia (ezetimibe) plus a statin has been shown to decrease CV events in high risk patients with ACS. IMPROVE-IT Trial not yet published but is coming very soon Reportedly there was a 6.4% risk reduction with the combination compared to statin alone

New Guidelines Published The American Gastroenterological Society published new guidelines for IBS in Gastroenterology More guidance on first line options for IBS-C and IBS-D A rigorous and evidence based summary of the drug literature